This Brief Summary does not include all the information needed to use MIEBO safely and effectively. See full Prescribing. Information for MIEBO. MIEBO (
Click here for full Prescribing Information for MIEBO. Indications and Important Safety Information for IC-8 Apthera IOL. INDICATIONS: The IC
MIEBO is the First and Only Prescription Eye Drop that Click here for full Prescribing Information for MIEBO. About Dry Eye
Please see accompanying Brief Summary of full Prescribing Information for MIEBO. References: 1. MIEBO. Prescribing Information. Bausch Lomb, Inc; 2024. 2
More about Miebo (perfluorohexyloctane ophthalmic) Compare alternatives; Pricing coupons; Reviews (27) Drug images; Side effects; During pregnancy; FDA approval history; Drug class: ophthalmic anti-inflammatory agents; En espa ol; Patient resources. Miebo drug information; Professional resources. Miebo prescribing information
MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBO (perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2024 -INDICATIONS AND USAGE- MIEBO (perfluorohexyloctane ophthalmic solution) is a semifluorinated
information. Description. Perfluorohexyloctane (Miebo) is a Miebo Prescribing Information. Bridgewater, NJ: Bausch Lomb
effectively. See full prescribing information for MIEBO. MIEBO (perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2024 INDICATIONS AND USAGE MIEBO (perfluorohexyloctane ophthalmic solution) is a semifluorinated alkane indicated for treatment of the signs and symptoms of dry eye disease. (1)
MIEBO (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease. IMPORTANT SAFETY INFORMATION. Patients should remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting. It is important for patients to use MIEBO exactly as prescribed.
Comments